Published Date : Apr 10, 2017
ALBANY, New York, April 10, 2017: A new market research report has been added by MarketResearchReports.biz to its vast repository of research studies. The 235-page, research study, titled “PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025,” offers a complete overview of the market, highlighting the key growth factors that are anticipated to influence the development in the next few years. The promising growth opportunities for the key players and the challenges being faced by them have been included in the scope of the study to provide a clear understanding of the global psoriatic arthritis market. As per the study, the market is expected to register a progressive 10.74% CAGR between 2016 and 2025.
The changing lifestyle patterns and the rising patient population are some of the key factors that are likely to encourage the growth of the global psoriatic arthritis market in the next few years. In addition, the rising awareness among consumers regarding psoriatic arthritis and the availability of drugs and treatments are estimated to accelerate the growth of the market in the forecast period. On the contrary, the rising cost of biologics, adverse side-effects of drugs, and the use of CAM by patients are projected to curb the growth of the global psoriatic arthritis market in the coming years.
Furthermore, the introduction of biosimilars and the increasing popularity of traditional and off-label treatment options are anticipated to accelerate the growth of the global psoriatic arthritis market in the coming years. In addition, the emergence of patient assistance programs, especially in developed regions are projected to create promising opportunities for key players operating in the market across the globe.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/990986
According to the study, North America is expected to experience a high growth throughout the forecast period. This region is expected to remain in the leading position and account for a key share of the overall market in the next few years. A significant rise in the consumer awareness regarding the therapeutics and the launch of assistance programs are projected to supplement the growth of the market in North America in the next few years. The share, size, and the anticipated growth rate of each regional segment have been given in the research study to offer a strong understanding of the market.
The global market for psoriatic arthritis is highly competitive in nature, thanks to the presence of a large number of players across the globe. The expansion of the product portfolio and the presence of a strong pipeline are some of the key factors that are likely to encourage the growth of the overall market in the next few years. Some of the key players operating in the psoriatic arthritis market across the globe are AbbVie, Pfizer, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Johnson & Johnson, Novartis, Amgen, Alder, and UCB.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com